Last reviewed · How we verify
NCT04236687
Prostate Artery Embolization Compared to Holmium Laser Enucleation of the Prostate for Benign Prostatic Hyperplasia
NA trial testing Holmium laser enucleation of the prostate in Benign Prostatic Hyperplasia in 100 participants. Status unknown.
1 February 2021
Quick facts
| Lead sponsor | Germans Trias i Pujol Hospital |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 100 |
| Start date | 1 February 2020 |
| Primary completion | 1 February 2021 |
| Estimated completion | 1 February 2022 |
| Sites | 1 location across Spain |
Drugs / interventions tested
- Holmium laser enucleation of the prostate
- Artery embolization of the prostate
Conditions studied
- Benign Prostatic Hyperplasia — all drugs for Benign Prostatic Hyperplasia →
Sponsor
Germans Trias i Pujol Hospital
Who can join
45 and older, male only, with Benign Prostatic Hyperplasia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to evaluate improvement of symptoms from benign prostatic hyperplasia (BPH) as assessed by the International Prostate Symptom Score (IPSS) for prostate artery embolization (PAE) with microspheres (Embozene™, 400µm) compared to conventional Holmium laser enucleation of the prostate (HoLEP).
Publications & conference data
5 peer-reviewed publications reference this trial (live from Europe PMC):
-
Update on the management of benign prostatic hyperplasia and the role of minimally invasive procedures.
Franco JVA, Tesolin P, Jung JH. · · 2023 · cited 32× · PMID 36910900 · DOI 10.1016/j.prnil.2023.01.002 -
Minimally invasive treatments for lower urinary tract symptoms in men with benign prostatic hyperplasia: a network meta-analysis.
Franco JV, Jung JH, Imamura M, Borofsky M, et al · · 2021 · cited 32× · PMID 34693990 · DOI 10.1002/14651858.cd013656.pub2 -
Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH, McCutcheon KA, Borofsky M, Young S, et al · · 2020 · cited 15× · PMID 33368143 · DOI 10.1002/14651858.cd012867.pub2 -
Prostatic arterial embolization for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia.
Jung JH, McCutcheon KA, Borofsky M, Young S, et al · · 2022 · cited 13× · PMID 35349161 · DOI 10.1002/14651858.cd012867.pub3 -
The State of Evidence in Prostate Artery Embolization.
Qamhawi Z, Little MW. · · 2022 · cited 3× · PMID 36561795 · DOI 10.1055/s-0042-1759733
Verify or expand the search:
- PubMed search for NCT04236687
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Holmium laser enucleation of the prostate
Trials testing the same drug.
- NCT06265519 — Association of Urine BDNF and NGF With Lower Urinary System Parameters · NA · recruiting
- NCT04342533 — Prospective Randomized Trial of Irritative Symptoms Severity Assessment After (HoLEP) Versus ThuFLEP · NA · unknown
- NCT03998150 — Holmium Laser vs Bipolar Enucleation of a Large Volume BPH: a Randomised Controlled Study · NA · completed
Other recruiting trials for Benign Prostatic Hyperplasia
Currently open trials in the same condition.
- NCT07444385 — A Study to Evaluate the Safety and Pharmacokinetics of AD-116 and AD-1161 in Healthy Adult Male Subjects · Phase 1 · recruiting
- NCT07293442 — Pelvic Floor Muscle Exercise for Lower Urinary Tract Symptoms After Surgery for Benign Prostatic Hyperplasia. · NA · recruiting
- NCT06657872 — Local Anesthesia With Schelin Catheter in Rezum Treatment: a Randomized Controlled Trial · NA · recruiting
- NCT06852859 — Patient-reported Pain and Symptom Relief During Three Months After Surgery for Benign Prostatic Hyperplasia · recruiting
- NCT06849258 — A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms · NA · recruiting
Other Germans Trias i Pujol Hospital trials
Trials by the same sponsor.
- NCT07064447 — Spanish Registry of Direct Cholangiopancreatoscopy by Single Operator · not yet recruiting
- NCT06670547 — Spanish Registry of Quality Indicators and Adverse Events of Endoscopic Retrograde Cholangiopancreatography · not yet recruiting
- NCT06337539 — Precision Psychiatry for Depression: Immune Response and Affective Symptoms as Predictors of Response to Antidepressants · not yet recruiting
- NCT07009054 — Program for the Promotion of Physical Exercise and Healthy Eating Among Population of Pakistani Origin With Obesity · NA · completed
- NCT07386275 — Impact of the eSalut Program in Hospital-at-Home (HOMeSALUT) · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04236687 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Germans Trias i Pujol Hospital
- Last refreshed: 22 January 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04236687.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing